Skip Navigation
Skip to contents



10 results

Novel Sunitinib Strategy in Metastatic Renal Cell Carcinoma on Hemodialysis: Intermittent Dose of Sunitinib after Hemodialysis

Yoon SH, Kim KH, Choi J, Kim GM, Kim JH, Kim HS, Park YN, Rha SY

  • Cancer Res Treat.
  • 2010 Sep;42(3):180-184.
The proper dose and schedule of sunitinib have yet to be established for patients with metastatic renal cell carcinoma (RCC) on hemodialysis. We reviewed two patients with metastatic RCC on...
Recurrent and Metastatic Trichilemmal Carcinoma of the Skin Over the Thigh: A Case Report

Yi HS, Sym SJ, Park J, Cho EK, Ha SY, Shin DB, Lee JH

  • Cancer Res Treat.
  • 2010 Sep;42(3):176-179.
Trichilemmal carcinoma (TC) is an uncommon cutaneous neoplasm that develops from the external root sheath of the hair follicle. It is considered to be a low-grade carcinoma with low metastatic...
A Case of Metachronous Metastasis to the Breast from Non-Small Cell Lung Carcinoma

Yoon MY, Song CS, Seo MH, Kim MJ, Oh TY, Jang UH, Kwag HJ, Kim HS, Lim SY, Lim SY, Lee SS

  • Cancer Res Treat.
  • 2010 Sep;42(3):172-175.
Breast metastases from an extramammary primary tumor are very rare and the prognosis for such patients is generally poor. We report here on a case of a 42-year-old female with...
Influence of Reduced Folate Carrier and Dihydrofolate Reductase Genes on Methotrexate-Induced Cytotoxicity

Yoon SA, Choi JR, Kim JO, Shin JY, Zhang X, Kang JH

  • Cancer Res Treat.
  • 2010 Sep;42(3):163-171.
PURPOSE: The aim of this study is to investigate the effect of genetic variations and the expression of the reduced folate carrier (RFC) and dihydrofolate reductase (DHFR) on the drug...
Bcl-2 as a Predictive Factor for Biochemical Recurrence after Radical Prostatectomy: An Interim Analysis

Cho IC, Chung HS, Cho KS, Kim JE, Joung JY, Seo HK, Chung J, Park WS, Hong EK, Lee KH

  • Cancer Res Treat.
  • 2010 Sep;42(3):157-162.
PURPOSE: The objective of this study was to determine Bcl-2 expression in localized prostate cancer and its potential role as a predictive factor for biochemical recurrence (BCR). MATERIALS AND METHODS: This...
Up-regulation of RhoGDI2 in Human Breast Cancer and Its Prognostic Implications

Moon HG, Jeong SH, Ju YT, Jeong CY, Lee JS, Lee YJ, Hong SC, Choi SK, Ha WS, Park ST, Jung EJ

  • Cancer Res Treat.
  • 2010 Sep;42(3):151-156.
PURPOSE: Recent research has identified many genes and proteins that play specific roles in the process of systemic metastasis in various types of cancer. Rho GDP dissociation inhibitor 2 (RhoGDI2)...
Prognostic Role of Rb, p16, Cyclin D1 Proteins in Soft Tissue Sarcomas

Shim BY, Yoo J, Lee YS, Hong YS, Kim HK, Kang JH

  • Cancer Res Treat.
  • 2010 Sep;42(3):144-150.
PURPOSE: The aim of this study was to determine the expressions of Rb, p16, and cyclin D1 in soft tissue sarcomas, and we also wanted to identify the prognostic factors...
Clinicopathological and Immunohistochemical Features of Gastointestinal Stromal Tumors

Kang YN, Jung HR, Hwang I

  • Cancer Res Treat.
  • 2010 Sep;42(3):135-143.
PURPOSE: The purpose of this study was to evaluate the clinicopathological features and immunohistochemical features of gastrointestinal stromal tumor (GIST), and specifically the expressions of platelet derived growth factor receptor...
Quality of Life of Long-Term Survivors after a Distal Subtotal Gastrectomy

Lee SS, Chung HY, Yu W

  • Cancer Res Treat.
  • 2010 Sep;42(3):130-134.
PURPOSE: The aim of this study was to investigate the impact of a distal subtotal gastrectomy on the quality of life (QoL). MATERIALS AND METHODS: The QoL data of 126 patients...
RNA Regulation in Neurologic Disease and Cancer

Darnell RB

  • Cancer Res Treat.
  • 2010 Sep;42(3):125-129.
The paraneoplastic neurologic diseases (PNDs) are brain degenerations that develop in the setting of clinically inapparent cancers. PNDs arise when common cancers express brain proteins, triggering an anti-tumor immune response...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: